Liraglutide studies: 1,219 papers with results
Page 6 of 25
- Use of flash glucose-sensing technology in patients with type 2 diabetes treated with liraglutide combined with CSII: a pilot study.
Yao MY · Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas · 2020
Randomized controlled trial · 12 results
- Effects of Lixisenatide Versus Liraglutide (Short- and Long-Acting GLP-1 Receptor Agonists) on Esophageal and Gastric Function in Patients With Type 2 Diabetes.
Quast DR · Diabetes care · 2020
Randomized controlled trial · 10 results
- Liraglutide causes large and rapid epicardial fat reduction.
Iacobellis G · Obesity (Silver Spring, Md.) · 2017
Randomized controlled trial · 3 results
- Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial.
Smits MM · Diabetologia · 2016
Randomized controlled trial · 4 results
- Effect of liraglutide on expression of inflammatory genes in type 2 diabetes.
Zobel EH · Scientific reports · 2021
Randomized controlled trial · 12 results
- Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome.
Xing C · Frontiers in endocrinology · 2022
Randomized controlled trial · 21 results
- Liraglutide changes postprandial responses of gut hormones involved in the regulation of gallbladder motility.
Nerild HH · Diabetes, obesity & metabolism · 2023
Randomized controlled trial · 6 results
- The Impact of Chronic Liraglutide Therapy on Glucagon Secretion in Type 2 Diabetes: Insight From the LIBRA Trial.
Kramer CK · The Journal of clinical endocrinology and metabolism · 2015
Randomized controlled trial · 4 results
- Effect of chronic liraglutide therapy and its withdrawal on time to postchallenge peak glucose in type 2 diabetes.
Tran S · American journal of physiology. Endocrinology and metabolism · 2018
Randomized controlled trial · 4 results
- Chronic liraglutide therapy induces an enhanced endogenous glucagon-like peptide-1 secretory response in early type 2 diabetes.
Kramer CK · Diabetes, obesity & metabolism · 2017
Randomized controlled trial · 3 results
- Activation of Glucagon-Like Peptide-1 Receptor Ameliorates Cognitive Decline in Type 2 Diabetes Mellitus Through a Metabolism-Independent Pathway.
Li Q · Journal of the American Heart Association · 2021
Randomized controlled trial · 5 results
- Liraglutide decreases energy expenditure and does not affect the fat fraction of supraclavicular brown adipose tissue in patients with type 2 diabetes.
van Eyk HJ · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2020
Randomized controlled trial · 3 results
- Macronutrient intake, appetite, food preferences and exocrine pancreas function after treatment with short- and long-acting glucagon-like peptide-1 receptor agonists in type 2 diabetes.
Quast DR · Diabetes, obesity & metabolism · 2021
Randomized controlled trial · 12 results
- Durable efficacy of liraglutide in patients with type 2 diabetes and pronounced insulin-associated weight gain: 52-week results from the Effect of Liraglutide on insulin-associated wEight GAiN in patients with Type 2 diabetes' (ELEGANT) randomized controlled trial.
de Wit HM · Journal of internal medicine · 2016
Randomized controlled trial · 7 results
- Effects of Liraglutide, Empagliflozin and Their Combination on Left Atrial Strain and Arterial Function.
Katogiannis K · Medicina (Kaunas, Lithuania) · 2024
Randomized controlled trial · 8 results
- Dose-response, efficacy, and safety of oral semaglutide monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): a 52-week, phase 2/3a, randomised, controlled trial.
Yamada Y · The lancet. Diabetes & endocrinology · 2020
Randomized controlled trial · 13 results
- Liraglutide accelerates colonic transit in people with type 1 diabetes and polyneuropathy: A randomised, double-blind, placebo-controlled trial.
Wegeberg AL · United European gastroenterology journal · 2020
Randomized controlled trial · 5 results
- A double-blind, placebo-controlled, randomised trial to assess the effect of liraglutide on ectopic fat accumulation in South Asian type 2 diabetes patients.
van Eyk HJ · Cardiovascular diabetology · 2019
Randomized controlled trial · 6 results
- Liraglutide relieves cardiac dilated function than DPP-4 inhibitors.
Hiramatsu T · European journal of clinical investigation · 2018
Randomized controlled trial · 8 results
- Improvement in binge eating in non-diabetic obese individuals after 3 months of treatment with liraglutide - A pilot study.
Robert SA · Obesity research & clinical practice · 2015
Randomized controlled trial · 8 results
- Liraglutide treatment causes upregulation of adiponectin and downregulation of resistin in Chinese type 2 diabetes.
Li D · Diabetes research and clinical practice · 2015
Randomized controlled trial · 3 results
- Comparative Efficacy of Endoscopic Sleeve Gastroplasty (Esg) Versus Liraglutide in Weight Loss and Remission Of Obesity-Related Comorbidities: Twelve Months Follow-Up Results.
Nigro S · Obesity surgery · 2025
Randomized controlled trial · 12 results
- Liraglutide Improves Myocardial Perfusion and Energetics and Exercise Tolerance in Patients With Type 2 Diabetes.
Chowdhary A · Journal of the American College of Cardiology · 2024
Randomized controlled trial · 5 results
- Effect of liraglutide on estimates of lipolysis and lipid oxidation in obese patients with stable coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial.
Anholm C · Diabetes, obesity & metabolism · 2019
Randomized controlled trial · 2 results
- Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes.
Santilli F · Diabetes care · 2017
Randomized controlled trial · 7 results
- Respiratory Effects of Treatment with a Glucagon-Like Peptide-1 Receptor Agonist in Patients Suffering from Obesity and Chronic Obstructive Pulmonary Disease.
Altintas Dogan AD · International journal of chronic obstructive pulmonary disease · 2022
Randomized controlled trial · 7 results
- Effects of liraglutide vs. lifestyle changes on soluble suppression of tumorigenesis-2 (sST2) and galectin-3 in obese subjects with prediabetes or type 2 diabetes after comparable weight loss.
Simeone P · Cardiovascular diabetology · 2022
Randomized controlled trial · 5 results
- Simplification of complex insulin regimens using canagliflozin or liraglutide in patients with well-controlled type 2 diabetes: A 24-week randomized controlled trial.
Ando Y · Journal of diabetes investigation · 2021
Randomized controlled trial · 7 results
- Effects of exenatide and liraglutide on 24-hour glucose fluctuations in type 2 diabetes.
Nagakura J · Endocrine journal · 2016
Randomized controlled trial · 12 results
- Combination metformin and liraglutide in PCOS: clinical efficacy in women and preclinical insights from gut microbiome modulation in rats.
Long XF · Frontiers in endocrinology · 2025
Randomized controlled trial · 18 results
- Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus.
Vilsbøll T · Diabetic medicine : a journal of the British Diabetic Association · 2008
Randomized controlled trial · 8 results
- Subcutaneous adipose tissue composition and function are unaffected by liraglutide-induced weight loss in adults with type 1 diabetes.
Wegeberg AM · Basic & clinical pharmacology & toxicology · 2021
Randomized controlled trial · 9 results
- Effects of Liraglutide Combined with Short-Term Continuous Subcutaneous Insulin Infusion on Glycemic Control and Beta Cell Function in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A Pilot Study.
Ke W · Journal of diabetes research · 2016
Randomized controlled trial · 5 results
- Blood-Brain Glucose Transfer in Alzheimer's disease: Effect of GLP-1 Analog Treatment.
Gejl M · Scientific reports · 2017
Randomized controlled trial · 1 result
- Liraglutide effects on epicardial adipose tissue micro-RNAs and intra-operative glucose control.
Iacobellis G · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2025
Randomized controlled trial · 11 results
- The effect of addition of liraglutide to high-dose intensive insulin therapy: a randomized prospective trial.
Lane W · Diabetes, obesity & metabolism · 2014
Randomized controlled trial · 4 results
- The pharmacokinetics, pharmacodynamics, and tolerability of liraglutide, a once-daily human GLP-1 analogue, after multiple subcutaneous administration in healthy Chinese male subjects.
Jiang J · Journal of clinical pharmacology · 2011
Randomized controlled trial · 7 results
- Enhancement of Impaired Olfactory Neural Activation and Cognitive Capacity by Liraglutide, but Not Dapagliflozin or Acarbose, in Patients With Type 2 Diabetes: A 16-Week Randomized Parallel Comparative Study.
Cheng H · Diabetes care · 2022
Randomized controlled trial · 9 results
- Heart rate acceleration with GLP-1 receptor agonists in type 2 diabetes patients: an acute and 12-week randomised, double-blind, placebo-controlled trial.
Smits MM · European journal of endocrinology · 2017
Randomized controlled trial · 7 results
- Effect of liraglutide on myocardial glucose uptake and blood flow in stable chronic heart failure patients: A double-blind, randomized, placebo-controlled LIVE sub-study.
Nielsen R · Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2019
Randomized controlled trial · 7 results
- Effect of immediate and prolonged GLP-1 receptor agonist administration on uric acid and kidney clearance: Post-hoc analyses of four clinical trials.
Tonneijck L · Diabetes, obesity & metabolism · 2018
Randomized controlled trial · 8 results
- GLP-1 Analog Modulates Appetite, Taste Preference, Gut Hormones, and Regional Body Fat Stores in Adults with Obesity.
Kadouh H · The Journal of clinical endocrinology and metabolism · 2020
Randomized controlled trial · 14 results
- Effects of Insulin Glargine and Liraglutide Therapy on Liver Fat as Measured by Magnetic Resonance in Patients With Type 2 Diabetes: A Randomized Trial.
Tang A · Diabetes care · 2015
Randomized controlled trial · 7 results
- Thromboxane-Dependent Platelet Activation in Obese Subjects with Prediabetes or Early Type 2 Diabetes: Effects of Liraglutide- or Lifestyle Changes-Induced Weight Loss.
Simeone P · Nutrients · 2018
Randomized controlled trial · 8 results
- Effect of the glucagon-like peptide-1 analogue liraglutide versus placebo treatment on circulating proglucagon-derived peptides that mediate improvements in body weight, insulin secretion and action: A randomized controlled trial.
Kim SH · Diabetes, obesity & metabolism · 2021
Randomized controlled trial · 10 results
- The effect of liraglutide, a long-acting glucagon-like peptide 1 derivative, on glycemic control, body composition, and 24-h energy expenditure in patients with type 2 diabetes.
Harder H · Diabetes care · 2004
Randomized controlled trial · 6 results
- Near-normalization of glycaemic control with glucagon-like peptide-1 receptor agonist treatment combined with exercise in patients with type 2 diabetes.
Mensberg P · Diabetes, obesity & metabolism · 2017
Randomized controlled trial · 7 results
- Effect of exercise combined with glucagon-like peptide-1 receptor agonist treatment on cardiac function: A randomized double-blind placebo-controlled clinical trial.
Jørgensen PG · Diabetes, obesity & metabolism · 2017
Randomized controlled trial · 4 results
- Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study.
Vadini F · International journal of obesity (2005) · 2020
Randomized controlled trial · 3 results
- Effect of liraglutide on dietary lipid-induced insulin resistance in humans.
Koska J · Diabetes, obesity & metabolism · 2018
Randomized controlled trial · 6 results